In This SectionTexas Health Research & Education Institute
Disease or Condition
Prevention of Alzheimer's Disease With Vitamin E and Selenium in Prostate Cancer Patients
To define the effect of selenium and vitamin E in combination in the reduction of the incidence of Alzheimer's disease (AD), as determined by mental status screening and clinical evaluation, in a population of men age 62 or older participating in the SELECT clinical trial (for prostate cancer patients).
Must be a SELECT SWOG-S0000 participant.
Participants must be 62 or older (men of African or Hispanic descent must be 60 or older).
Participants must not have neurological conditions such as Alzheimer's Disease, dementia, Huntington's Disease or Epilepsy.